PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.\', \'Research Development Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.\', \'Endocrinology Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Internal Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Pathology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Medicine, Section of Endocrinology, Nutrition, Diabetes and Weight Management, Boston University Medical Center, Boston, Massachusetts, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0239799
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 32976513
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all